Gorman Erin B, Klorman Rafael, Thatcher Joan E, Borgstedt Agneta D
University of Rochester, Rochester, NY 14627-0266, USA.
J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):808-16. doi: 10.1097/01.chi.0000214191.57993.dd.
To compare the effects of methylphenidate on attention-deficit/hyperactivity disorder (ADHD) subtypes.
Nineteen ADHD/inattentive (ADHD/I) and 22 ADHD/combined (ADHD/C) 6- to 12-year-old children entered a 6-week, double-blind trial of placebo and methylphenidate in divided doses (0.94 +/- 0.02 mg/kg/day = 33.06 +/- 1.40 mg/day). ADHD children received a restricted arithmetic task without medication before the trial and after their noon dose on the last day of each phase. Thirty-four unmedicated controls were tested at comparable time points. Parents and teachers rated ADHD children before and after each phase of the trial; parents rated controls before the study.
Controls had marginally better arithmetic performance than children with ADHD/C who outperformed ADHD/I children. Unmedicated children with ADHD exceeded controls in task-incompatible behaviors during restricted arithmetic. Under methylphenidate, both ADHD subtypes reached control levels of arithmetic performance and task-incompatible behavior. Before the trial, parents rated children with both ADHD subtypes higher than controls on inattention, hyperactivity, and oppositionality/aggression and parents and teachers rated ADHD/C children higher than ADHD/I children on hyperactivity and oppositionality/aggression but not inattention. Methylphenidate lowered parent and teacher ratings of inattention and hyperactivity for those with both ADHD subtypes, but ratings of children with ADHD/C decreased more in hyperactivity and aggression.
Methylphenidate ameliorated task-incompatible behavior, arithmetic performance, and inattention comparably in both ADHD subtypes, whereas medication reduced hyperactivity and aggression largely in children with ADHD/C.
比较哌甲酯对注意力缺陷多动障碍(ADHD)各亚型的影响。
19名6至12岁注意力不集中型ADHD(ADHD/I)儿童和22名混合型ADHD(ADHD/C)儿童进入一项为期6周的安慰剂和哌甲酯双盲试验,哌甲酯采用分次给药(0.94±0.02毫克/千克/天 = 33.06±1.40毫克/天)。ADHD儿童在试验前及各阶段最后一天中午服药后接受一项受限算术任务测试,且测试时未服药。34名未服药的对照儿童在相应时间点接受测试。在试验的各阶段前后,由家长和教师对ADHD儿童进行评分;在研究前由家长对对照儿童进行评分。
对照儿童的算术表现略优于ADHD/C儿童,而ADHD/C儿童的表现优于ADHD/I儿童。未服药的ADHD儿童在受限算术任务中的任务不兼容行为超过对照儿童。在哌甲酯治疗下,两种ADHD亚型的算术表现和任务不兼容行为均达到对照水平。试验前,家长对两种ADHD亚型儿童在注意力不集中、多动及对立性/攻击性方面的评分高于对照儿童,家长和教师对ADHD/C儿童在多动及对立性/攻击性方面的评分高于ADHD/I儿童,但在注意力不集中方面并非如此。哌甲酯降低了两种ADHD亚型儿童家长和教师对其注意力不集中和多动的评分,但ADHD/C儿童在多动和攻击性方面的评分下降幅度更大。
哌甲酯在两种ADHD亚型中对任务不兼容行为、算术表现和注意力不集中的改善程度相当,而药物治疗在很大程度上降低了ADHD/C儿童的多动和攻击性。